Absci Corp ABSI:NASDAQ

RT Quote | Last NASDAQ LS, VOL From CTA | USD
after hours iconAfter Hours: Last | 4:01 PM EDT
4.00UNCH (UNCH)
Volume
3,809
Close
4.00quote price arrow down-0.23 (-5.44%)
Volume
305,915
52 week range
2.93 - 23.62
Loading...
  • Open4.17
  • Day High4.17
  • Day Low3.93
  • Prev Close4.23
  • 52 Week High23.62
  • 52 Week High Date08/23/21
  • 52 Week Low2.93
  • 52 Week Low Date06/13/22

Key Stats

  • Market Cap371.36M
  • Shares Out92.84M
  • 10 Day Average Volume2.06M
  • Dividend-
  • Dividend Yield-
  • Beta-
  • YTD % Change-51.22

KEY STATS

  • Open4.17
  • Day High4.17
  • Day Low3.93
  • Prev Close4.23
  • 52 Week High23.62
  • 52 Week High Date08/23/21
  • 52 Week Low2.93
  • 52 Week Low Date06/13/22
  • Market Cap371.36M
  • Shares Out92.84M
  • 10 Day Average Volume2.06M
  • Dividend-
  • Dividend Yield-
  • Beta-
  • YTD % Change-51.22

RATIOS/PROFITABILITY

  • EPS (TTM)-1.25
  • P/E (TTM)-3.21
  • Fwd P/E (NTM)-4.75
  • EBITDA (TTM)-92.264M
  • ROE (TTM)-111.72%
  • Revenue (TTM)4.81M
  • Gross Margin (TTM)-
  • Net Margin (TTM)-2,223.07%
  • Debt To Equity (MRQ)4.34%

EVENTS

  • Earnings Date11/09/2022(est)
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Absci Corp

There is no recent news for this security.

Profile

MORE
Absci Corporation is a drug and target discovery company. The Company has developed an Integrated Drug Creation platform to identify novel drug targets, discover biotherapeutic candidates, and generate the cell lines to manufacture them in a single process. It uses synthetic biology technologies and deep learning artificial intelligence (AI) to predict, identify, design, construct, screen, select and scale production of biologic drug candidates, and learn from the data it...
Ivana Magovcevic-Liebisch J.D., Ph.D.
Independent Chairman of the Board
Sean McClain
Chief Executive Officer, Founder, Director
Gregory Schiffman
Chief Financial Officer
Matthew Weinstock Ph.D.
Chief Technology Officer
Sarah Korman J.D., Ph.D.
General Counsel and Corporate Secretary
Address
18105 Se Mill Plain Blvd, Suite 350
Vancouver, WA
98683
United States

Top Peers

SYMBOLLASTCHG%CHG
GBIO
Generation Bio Co
5.23-0.76-12.69%
BTAI
BioXcel Therapeutics Inc
14.44-0.22-1.50%
ALDX
Aldeyra Therapeutics Inc
6.94-0.04-0.57%
ADGI
Adagio Therapeutics Inc
4.20-0.31-6.87%
VRDN
Viridian Therapeutics Inc
23.58+0.33+1.42%